March 27, 2006
Pharmaceutical companies saw particularly large NHI price reductions for anti-ulcer, statin, antihypertensive, and anti-allergy drugs in the recently announced NHI price revision for this year. These are tough markets, each with multiple competing products. Competition Heats Up among Major Therapeutic...read more